Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Maitland
Inova Health Care Services, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Actelion
Other : Payment for services (e.g., consulting fees, honoraria, paid authorship)
My spouse, (b)(6), is an Inova-employed cardiologist/clinical-epidemiologist with expertise in the orphan disease- pulmonary arterial hypertension. For more than a decade, she has been a national/international leader in the development of new treatments for this disease and the design of clinical trials to evaluate different methods of testing new and existing treatments, risk stratification of patients, etc. She, therefore, is routinely consulted by large pharmaceutical companies and new biotechs on their efforts to develop new therapeutics. As a physician-educator she also performs grant reviews or curriculum development with her peers. Her efforts have effectively nothing to do with my research at Inova but are fully disclosed here to be compliant with COI regulations. I have not received any direct personal remuneration from any for-profit entity in 2017 and do not expect to receive any in 2018.
Computational modeling of tumor burden by CT to advance cancer therapeutics
This project teams cancer physicians, radiologists, and industry scientists to develop improved methods for testing new cancer drugs in patients. These experts will first use new methods to analyze CT scans from patients who participated in previous clinical trials. The research team will then use this information to develop new, quicker ways to test new cancer drugs in small numbers of patients to tell whether or not these treatments show promise for helping others.
Filed on March 12, 2018.
Tell us what you know about Michael Maitland's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Maitland filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Maitland | Inova Health Care Services | Conflict of Interest | Actelion | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.